In gastric cancer (GC), tumor-derived GM-CSF activates neutrophils and induces PD-L1 expression on neutrophil via Jak-Stat3 signaling pathway, therefore inhibiting T-cell immunity and contribute to the GC progression (127). The gene discussed is CSF2; the disease is gastric cancer.